MARKET

CYPH

CYPH

Cypherpunk Technologies Inc
NASDAQ
1.060
-0.040
-3.64%
After Hours: 1.040 -0.02 -1.89% 19:55 01/16 EST
OPEN
1.070
PREV CLOSE
1.100
HIGH
1.095
LOW
1.020
VOLUME
2.36M
TURNOVER
--
52 WEEK HIGH
3.700
52 WEEK LOW
0.2223
MARKET CAP
60.05M
P/E (TTM)
-0.8624
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CYPH last week (0112-0116)?
Weekly Report · 17h ago
Weekly Report: what happened at CYPH last week (0105-0109)?
Weekly Report · 01/12 09:35
Largest borrow rate increases among liquid names
TipRanks · 01/06 13:45
Weekly Report: what happened at CYPH last week (1229-0102)?
Weekly Report · 01/05 09:33
Crypto Currents: Cantor says bitcoin could be weak for next few months
TipRanks · 01/02 14:40
Crypto Currents: Trump media to launch token for shareholders
TipRanks · 12/31/2025 17:15
Cypherpunk Technologies restructures CoinXit equity compensation agreement
TipRanks · 12/30/2025 21:29
Cypherpunk Technologies Grants Over 5.4 Million RSUs to Consultant CoinXit
Reuters · 12/30/2025 21:14
More
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.

Webull offers Cypherpunk Technologies Inc stock information, including NASDAQ: CYPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYPH stock methods without spending real money on the virtual paper trading platform.